Drake, L., Hordinsky, M., Fiedler, V., Swinehart, J., Unger, W
This is where the newest generation of FDA-approved GLP-1 medications shine, helping to reset your bodys natural hunger cues
The effect on stroke is remarkable (and was significant in the trials of both semaglutide and dulaglutide), amounting to an 18% risk reduction, also because the other class of new antidiabetic agents with cardiovascular benefits, the SGLT2-inhibitors, show no a similar effect on stroke (but do have a significant effect on heart failure) [24]
"That broader availability though still limited may be what's driving GLP-1 usage higher overall." Related: Goldman Sachs doubles down on Novo stock target after key event This story was originally published by TheStreet on Jul 8, 2026, where it first appeared in the Health section
Guided by experts Your treatment is not built from a template
Verify state availability: Confirm the program services are available in your specific state before beginning the intake process